Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
INVS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANAPC11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SARM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
YARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM214A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCTN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPT1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMPPE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ATL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLNB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MINA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC43A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on